沙特民防部门：胡塞武装向麦加和麦地那地区发射的弹道导弹遭拦截，拦截产生的弹片坠落地面。

巴勒斯坦政府：以色列在西岸的升级行动需要紧急国际干预。

Conference data published Saturday show Amgen’s Imdelltra combined with AstraZeneca’s Imfinzi cut the risk of death by 58% versus Imfinzi alone in extensive‑stage small‑cell lung cancer. Median overall survival was 21.1 months for the combo versus 12.7 months for Imfinzi monotherapy. Imfinzi is currently the post‑chemotherapy standard for patients without progression after first‑line chemo. Amgen CMO Paul Burton said earlier use of Imdelltra produced greater clinical benefit and called the result unprecedented for advancing treatment in this indication.